Paper30635339
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
Luke JJ and 4 others. Clin Cancer Res, 2019. Cited by 620 papers, by iCite.
Cite this record
ConductScience Library. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers. Papers, record 30635339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30635339
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| beta Catenin | Major topic |
| Humans | |
| Mutation | |
| Tumor Microenvironment | |
| Wnt Signaling Pathway |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| L30 CA199313 | NCI NIH HHS | United States | L30CA199313 | PubMed and NIH | NIH RePORTER |
| L30 CA179265 | NCI NIH HHS | United States | L30CA179265 | PubMed and NIH | NIH RePORTER |
| P30 CA014599 | NCI NIH HHS | United States | P30CA014599 | PubMed and NIH | NIH RePORTER |
| R00 CA204595 | NCI NIH HHS | United States | K99CA204595 | PubMed and NIH | NIH RePORTER |
| K08 CA234392 | NCI NIH HHS | United States | K08CA234392 | PubMed and NIH | NIH RePORTER |
| R35 CA210098 | NCI NIH HHS | United States | R35CA210098 | PubMed and NIH | NIH RePORTER |
| K99 CA204595 | NCI NIH HHS | United States | K99CA204595 | PubMed and NIH | NIH RePORTER |
| UL1 TR002389 | NCATS NIH HHS | United States | UL1TR002389 | PubMed and NIH | NIH RePORTER |
| R00CA204595 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30837277 | Tumor Landscapes: β-Catenin Drives Immune Desertification. | https://conductscience.org/library/papers/30837277 |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10966653 | Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. | Nat Struct Biol | 2000 | https://conductscience.org/library/papers/10966653 | PubMed |
| 2 | 11682119 | Controlling the false discovery rate in behavior genetics research. | Behav Brain Res | 2001 | https://conductscience.org/library/papers/11682119 | PubMed |
| 3 | 12799363 | Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12799363 | PubMed |
| 4 | 14612901 | The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14612901 | PubMed |
| 5 | 19293190 | Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. | Cancer Res | 2009 | https://conductscience.org/library/papers/19293190 | PubMed |
| 6 | 20525992 | Improved survival with ipilimumab in patients with metastatic melanoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20525992 | PubMed |
| 7 | 20693853 | Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy. | Cancer J | 2010 | https://conductscience.org/library/papers/20693853 | PubMed |
| 8 | 21527027 | GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. | Genome Biol | 2011 | https://conductscience.org/library/papers/21527027 | PubMed |
| 9 | 22146893 | An immune-active tumor microenvironment favors clinical response to ipilimumab. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22146893 | PubMed |
| 10 | 22658127 | Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22658127 | PubMed |
| 11 | 23016862 | Wnt/beta-catenin signaling and small molecule inhibitors. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23016862 | PubMed |
| 12 | 23579075 | Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. | Curr Opin Immunol | 2013 | https://conductscience.org/library/papers/23579075 | PubMed |
| 13 | 24048123 | Innate and adaptive immune cells in the tumor microenvironment. | Nat Immunol | 2013 | https://conductscience.org/library/papers/24048123 | PubMed |
| 14 | 24336805 | Causal analysis approaches in Ingenuity Pathway Analysis. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24336805 | PubMed |
| 15 | 24485249 | voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. | Genome Biol | 2014 | https://conductscience.org/library/papers/24485249 | PubMed |
| 16 | 24735922 | Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24735922 | PubMed |
| 17 | 25428505 | PD-1 blockade induces responses by inhibiting adaptive immune resistance. | Nature | 2014 | https://conductscience.org/library/papers/25428505 | PubMed |
| 18 | 25594174 | Molecular and genetic properties of tumors associated with local immune cytolytic activity. | Cell | 2015 | https://conductscience.org/library/papers/25594174 | PubMed |
| 19 | 25891173 | Pembrolizumab versus Ipilimumab in Advanced Melanoma. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25891173 | PubMed |
| 20 | 25970248 | Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. | Nature | 2015 | https://conductscience.org/library/papers/25970248 | PubMed |
Cited by496
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 620 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974102 | Exploring the potential role of PD-L2 in primary melanoma immunotherapy resistance: a hypothesis-driven dual-ligand framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42974102 | PubMed |
| 42972057 | The genomic and epigenomic evolution of colorectal cancer. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42972057 | PubMed |
| 42936250 | Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC-ICI combinations, and global real-world integration. | Front Immunol | 2026 | https://conductscience.org/library/papers/42936250 | PubMed |
| 42930143 | β-Catenin Signaling in Hepatocellular Carcinoma: Mechanisms of Therapeutic Resistance and Emerging Therapeutic Strategies. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930143 | PubMed |
| 42928456 | Molecular and Immune Features of Metastatic Prostate Cancer in Hispanic and Non-Hispanic American Men. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42928456 | PubMed |
| 42927598 | Peripheral immune tolerance as a driver of tumor immune escape and therapy resistance. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42927598 | PubMed |
| 42909279 | Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translation. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42909279 | PubMed |
| 42907489 | Spatial transcriptomic sequencing identifies lipid metabolism and mitochondrial respiration as central features of T cell excluded esophageal adenocarcinomas. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42907489 | PubMed |
| 42859213 | CT radiomics and topology-based intratumoral heterogeneity for preoperative prediction of nuclear β-catenin expression in hepatocellular carcinoma. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/42859213 | PubMed |
| 42830947 | Immune-Cell Dynamics in the Tumor Microenvironment: Implications for Cancer Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42830947 | PubMed |
| 42824375 | Mapping the physical topology of the tumor immune microenvironment: macroscopic image fractals as surrogate markers for immune exclusion phenotype and treatment resistance in colorectal cancer liver metastases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42824375 | PubMed |
| 42787171 | Nomograms and an inflammation model predict immunotherapy prognosis in unresectable hepatocellular carcinoma: from survival and response. | Front Oncol | 2026 | https://conductscience.org/library/papers/42787171 | PubMed |
| 42780747 | Bispecific antibodies in gastrointestinal cancers: current applications and future perspectives. | Front Oncol | 2026 | https://conductscience.org/library/papers/42780747 | PubMed |
| 42763389 | Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42763389 | PubMed |
| 42761969 | Beyond mitotane: next-generation therapeutic landscapes in adrenocortical carcinoma. | Endocr Oncol | 2026 | https://conductscience.org/library/papers/42761969 | PubMed |
| 42761382 | Influence of oncogenic drivers and signaling pathways on immune checkpoint inhibitor efficacy in NSCLC. | Genes Dis | 2027 | https://conductscience.org/library/papers/42761382 | PubMed |
| 42754734 | Spatial transcriptomics reveals immune remodeling in lymph nodes of gastric adenocarcinoma. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/42754734 | PubMed |
| 42738783 | Heating the Cold: Overcoming Immunotherapy Resistance in Microsatellite-Stable Colorectal Cancer: A Systematic Review. | Molecules | 2026 | https://conductscience.org/library/papers/42738783 | PubMed |
| 42738312 | Deconstructing Exceptional Responses to Immune Checkpoint Inhibition in Recurrent or Metastatic Head and Neck Carcinoma: A Site-Specific Clinical-Biological Synthesis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738312 | PubMed |
| 42736558 | Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42736558 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30635339
GET https://conductscience.org/api/papers/v1/30635339/references?page=2